Pilot study: Biomarkers for diagnosis of neutrophil inflammatory/ allergic asthma

Completed

• Conditions: (Severe) asthma; 10001708

• Registration Number: NL-OMON43341
• Lead Sponsor: Rijnstate Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

Healthy controls

Exclusion Criteria

-People with asthma
-People suffering form other (chronic, pulmonary or autoimmune) diseases than asthma
-People that had an infection within two weeks prior to investigation
-People having immunodeficiency
-People who take steroids, antibiotics or probiotics

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Th1/Th2/Th17 patterns in the nasal lavage, saliva and blood of healthy controls<br /><br>by measuring cytokine levels.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>